Диссертация (1174271), страница 18
Текст из файла (страница 18)
2006. 200 p.166. Faure E., et al. Bacterial lipopolysaccharide activates NF-kappa B throughtoll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differentialexpression of TLR-4 and TLR-2 in endothelial cells//J Biol Chem, 2000. Vol. 275 (15).P.
11058-63.167. Fazeli A., Bruce C., and Anumba D.O. Characterization of Toll-likereceptors in the female reproductive tract in humans//Hum Reprod. 2005. Vol. 20(5). P.1372-8.168. Fu Y., et al. Lipopolysaccharide increases Toll-like receptor 4 anddownstream Toll-like receptor signaling molecules expression in bovine endometrialepithelial cells//Vet Immunol. Immunopathol.
2013. Vol. 151 (1-2). P. 20-7.169. Garcia J.R., Krause A., Schulz S. Human beta-defensin 4: a novelinductible peptide with a specific with a specific salt-sensitive spectrum of antimicrobialactivity//FASEB J. 2001. Vol. 15 (10). P.1819-21.170. Gebeh A.K., et al. Ectopic pregnancy is associated with high anandamidelevels and aberrant expression of FAAH and CB1 in fallopian tubes//J.
Clin Endocrinol.Metab. 2012. Vol. 97(8). P. 2827-35.171. Ghia P., et al., Age-dependent accumulation of monoclonal CD4+, CD8+double positive T lymphocytes in the peripheral blood of the elderly//Br. J Haematol.2007. Vol. 139 (5). P. 780-90.172. Gray-Swain M.R. and Peipert J.F. Pelvic inflammatory disease inadolescents. //Curr. Opin. Obstet. Gynecol. 2006.
Vol. 18 (5). P. 503-10.107173. Grodstein F. and Rothman K.J. Epidemiology of pelvic inflammatorydisease//Epidemiology 1994. Vol. 5 (2). P. 234-42.174. Guerra – Infante F.M. et al. Evaluation of an indirect immunofluorescenceassay for detecting Chlamydia trachomatis as a method for diagnosing tubal factorinfertility in Mexican women//Int.
J. Fertil. Womens Med. 2003. Vol. 48 (2). P. 74-82.175. Gulden E. and Wen L. Toll-Like Receptor Activation in Immunity vs.Tolerance in Autoimmune Diabetes//Front Immunol. 2014. Vol. 5. 119p.176. Hayashi T., et al. Novel Synthetic Toll-Like Receptor 4/MD2 LigandsAttenuate Sterile Inflammation//J. Pharmacol Exp Ther. 2014.
Vol. 350 (2). P. 330-40.177. Hirata T., Osuga Y., Hirota Y.et al. Evidence for the presense of toll-likerecepnor 4 sistem in the human endometrium//J. Clin. Endocrinol. Metab. 2005. Vol.90(1). P. 548 – 56.178. Hoof K. Pelvic inflammatory disease. Ther Umsch, 2007. Vol. 64(7). P.365-8.179. Horner P.J. and D. Taylor-Robinson, Screening for non-gonococcalurethritis//Int J STD AIDS, 2003. Vol. 14(10). P. 715.180. Ibarrola Vidaurre M., et al.
Infectious pathology: vulvovaginitis, sexuallytransmitted diseases, pelvic inflammatory disease, tubo-ovarian abscesses//An Sist SanitNavar. 2009. 32 Suppl 1.P. 29-38.181. Itoh H., et al. Human oviductal stromal fibroblasts, but not oviductalepithelial cells, express Toll-like receptor 4: the site-specific mucosal immunity of thehuman fallopian tube against bacterial infection//Am J.
Reprod. Immunol. 2006. Vol. 56(2). P. 91-101.182. Kavanagh K., et al., Estimation of the risk of tubal factor infertilityassociated with genital chlamydial infection in women: a statistical modelling stud//Int JEpidemiol. 2013. Vol. 42(2). P. 493-503.183. King A.E., Fleming D. C., Critchley H.O.et al. Differential expression ofthe natural antimicrobials, beta-defensis 3 and 4, in human endometrium//J. Reprod.Immunol. 2003. Vol. 59 (1). P.
1 – 16.108184. Klavinskis L.S., et al. Intranasal immunization with plasmid DNA-lipidcomplexes elicits mucosal immunity in the female genital and rectal tracts//J. Immunol.1999. Vol. 162(1). P. 254-62.185. Koga K., et al. Toll-like Receptors at the Maternal-Fetal Interface inNormal Pregnancy and Pregnancy Complications//Am. J.
Reprod Immunol. 2014.186. Kovalenko V.L. et al. The characteristics of the epithelium and endometrialextracellular matrix in miscarriage during early pregnancy associated with chronicendometritis//Arkh. Patol. 2009. Vol. 71(5). P. 40-3.187. Lauper U. and Schlatter C. Adnexitis and pelvic inflammatory disease//Gynakol Geburtshilfliche Rundsch. 2005.
Vol. 45(1). P. 14-8.188. Lepe Jimenez, J.A., et al., Update on the epidemiology, diagnosis andtreatment of sexually-transmitted infections//Enferm Infecc Microbiol Clin. 2008. 26Suppl 13. P. 25-31.189. Li J. et al. Regulation of toll-like receptor expression in human conjunctivalepithelial cells//Mediators Inflamm. 2014. P. 493-596.190.
Li Q. et al. Toll-like receptor 4-mediated signaling regulates IL-7-drivenproliferation and differentiation of B-cell precursors//Cell Mol. Immunol. 2014. Vol.11(2). P. 132-40.191. Lund J. et al. Toll-like receptor 9-mediated recognition of Herpes simplexvirus-2 by plasmacytoid dendritic cells//J. Exp. Med. 2003. Vol. 198(3). P. 513-20.192. Lush L., Walt G., and Ogden J.
Transferring policies for treating sexuallytransmitted infections: what's wrong with global guidelines? //Health Policy Plan. 2003.Vol. 18(1). P. 18-30.193. Malhotra M. et al. Genital Chlamydia trachomatis: an update//Indian J MedRes. 2013. Vol. 138(3). P. 303-16.194. Mardh P.A. Tubal factor infertility, with special regard to chlamydialsalpingitis//Curr Opin Infect Dis. 2004. Vol. 17(1). P. 49-52.195.
Mishori R., McClaskey E.L., and WinklerPrins V.J. Chlamydia trachomatisinfections: screening, diagnosis, and management//Am Fam Physician. 2012. Vol.86(12). P. 1127-32.109196. Morhason-Bello I. et al. The prevalence and outcome of asymptomaticchlamydial infection screening among infertile women attending gynecological clinic inibadan, South west Nigeria//Ann Med Health Sci Res. 2014.Vol. 4(2). P. 253-7.197.
Motoi Y. et al. Lipopeptides are signaled by Toll-like receptor 1, 2 and 6 inendolysosomes//Int. Immunol. 2014.198. Munday P.E. Clinical aspects of pelvic inflammatory disease//HumReprod, 1997. Vol. 12(11 Suppl). P. 121-6.199. Nunez-Troconis J.T. Mycoplasma hominis and Ureaplasma urealyticum indifferent gynecologic diseases//Invest Clin. 1999. Vol. 40(1).
P. 9-24.200. Oppenheim J.J., Biragyn A., Kuvak L.W. et all Roles of antimicrobicalpeptides such as defensins in innate and adaptable//Ann Rheum Dis. 2007.Vol. 62. Sup.2. P. 17 – 21.201. Palter S.F. et al. Interleukin-8 in the human fallopian tube//J ClinEndocrinol Metab. 2001. Vol.
86 (6). P. 2660-7.202. Pasare C. and Medzhitov R. Toll-like receptors: balancing host resistancewith immune tolerance//Curr Opin Immunol. 2003. Vol. 15 (6). P. 677 – 82.203. Pulise R., Lyman D. Gonococcal-pelvis inflammatory diseases. – N.Y.//St.J. Med. 1979. Vol. 79 (11). P. 1728 – 1729.204. Reekie J. et al. Hospitalisations for pelvic inflammatory disease temporallyrelated to a diagnosis of Chlamydia or gonorrhoea: a retrospective cohort study//PLoSOne.
2014. Vol. 9(4). P. e94361.205. Rekart M.L., et al., Chlamydia public health programs and theepidemiology of pelvic inflammatory disease and ectopic pregnancy//J.Infect Dis.2013.V. 207 (1). P. 30-8.206. Sambrook J., MacCallum P. Molecular Cloning: A Laboratory Manual//(Third Edition). 2001. – 2344 p.207.
Schaefer T.M., Desouza K., Fahey J.V.et al. Toll-like receptor (TLR0ecxpression and TLR-mediated cytokine/chemokine production by human uterineepithelial cells//Immunology. 2004. Vol. 112 (3). P. 428 – 36.110208. Schnee D.M., Pelvic inflammatory disease//J Pediatr Adolesc Gynecol.2009. Vol. 22 (6). P. 387-9.209. Seledtsov V.I. and Seledtsova G.V.
A balance between tissue-destructiveand tissue-protective immunities: a role of toll-like receptors in regulation of adaptiveimmunity//Immunobiology. 2012. Vol. 217 (4). P. 430-5.210. Sewell C.A. and Anderson J.R. Cytomegalovirus disease in the lowerfemale genital tract//AIDS Patient Care STDS. 2001.
Vol. 15 (9). P. 459-62.211. Shang L., et al. Selective Antibody Intervention of Toll-like Receptor 4Activation through Fc gamma Receptor Tethering//J Biol Chem. 2014. Vol. 289 (22). P.15309-15318.212. Shimazu T., et al. Immunobiotic Lactobacillus jensenii elicits antiinflammatory activity in porcine intestinal epithelial cells by modulating negativeregulators of the Toll-like receptor signaling pathway//Infect Immun.
2012. Vol. 80 (1).P.276-88.213. Stahl J.P. Sexually transmitted diseases in women, mothers, under-agefemales. 7th Consensus Conference on Antiinfectious therapy. Paris, 3 November 1993.//Arch Pediatr. 1994. Vol. 1 (7). P. 674-80.214. Stifano G., et al. Chronic Toll-like receptor 4 stimulation in skin inducesinflammation, macrophage activation, transforming growth factor beta signature geneexpression, and fibrosis//Arthritis Res Ther. 2014. Vol. 16 (4). P. R136.215.
Straszewski-Chavez S.L., Abrahams V.M. and Mor G. The role ofapoptosis in the regulation of trophoblast survival and differentiation duringpregnancy//Endocr Rev. 2005.Vol. 26 (7). P. 877-97.216. Subair O. et al. Trainees and the management of ectopic pregnancy//J.Obstet Gynaecol. 2004. Vol. 24 (7). P. 811-2.217.
Subair O., Uku A. and Amu O. Hydrosalpinx complicating routine doubleclip sterilisation//J. Obstet Gynaecol. 2004. Vol. 24 (8). P. 942-3.218. Sulak P.J., Sexually transmitted diseases//Semin Reprod Med. 2003. Vol.21 (4). P. 399-413.111219. Sweet R.L. Pelvic Inflammatory Disease: Current Concepts of Diagnosisand Management//Curr Infect Dis Rep. 2012.220. Turner M.L. et al. Epithelial and stromal cells of bovine endometrium haveroles in innate immunity and initiate inflammatory responses to bacterial lipopeptides invitro via Toll-like receptors TLR2, TLR1, and TLR6//Endocrinology.
2014. Vol.155(4). P. 1453-65.221. Wiesner J., Vilcinskas A. Antimicrobical peptides: the ancient arm of thehuman immune system. //Landes Bioscience.- Verulence. 2010 Sep-Oct. Vol. 1 (5). P.440-64..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
